ArticleFrontiers in pharmacology2023

Myricetin suppresses TGF-β-induced epithelial-to-mesenchymal transition in ovarian cancer.

Hui-Wen Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.